Maximum quantity allowed is 999
Please select the quantity
CAS RN: 103060-53-3 | Product Number: D4229
Daptomycin
×
![]()
×
Purity: >94.0%(HPLC)(N)
Synonyms:
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 100MG |
¥380.00
|
6 | Contact Us | ≥40 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | D4229 |
| Purity / Analysis Method | >94.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__7__2H__1__0__1N__1__7O__2__6 = 1,620.69 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 103060-53-3 |
| Reaxys Registry Number | 8186242 |
| PubChem Substance ID | 172089104 |
| Merck Index (14) | 2823 |
| MDL Number | MFCD08282794 |
Specifications
| Appearance | White to Yellow to Orange powder to crystal |
| Purity(HPLC) | min. 94.0 area% |
| Purity(with Total Nitrogen) | min. 94.0 % |
| NMR | confirm to structure |
Properties (reference)
| Maximum Absorption Wavelength | 260(EtOH) nm |
| Solubility (soluble in) | Methanol |
GHS
Related Laws:
| RTECS# | HB5626000 |
Transport Information:
| Customs Control Conditions (Q) | Q类 （糖类，生物碱类，抗生素类，激素类） |
Application
Studies on the Antibiotic Activity of Daptomycin
References
- Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus
- In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
- Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
- Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus
- Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
- Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.